Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation

Bone

Volumn 25, Issue 3, 1999, Pages 269-278

  Haynes, D R ^a   Atkins, G J ^a   Loric, M ^a   Crotti, T N ^a   Geary, S M ^b   Findlay, D M ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Hemopoietic cells; Interleukin 1 and 1 ; Mitochondrial RNA (mRNA); Osteoclasts; Stromal cells

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; MITOCHONDRIAL RNA; PROSTAGLANDIN E2;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; SIGNAL PROCESSING; STROMA CELL;

ACID PHOSPHATASE; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CHOLECALCIFEROL; COCULTURE TECHNIQUES; DEXAMETHASONE; DINOPROSTONE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-1; ISOENZYMES; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MONOCYTES; OSTEOCLASTS; RECEPTORS, CALCITONIN; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 0032839405     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00176-3     Document Type: Article

References (33)

1. Bakouche O., Moreau J.L., Lachman L.B. Induction of IL-1 Independent production of IL-1 alpha and IL-1 beta . Cytokine. 4:1992;106-113.
2. Brandstrom H., Jonsson K.B., Ohlsson C., Vidal O., Ljunghall S., Ljunggren O. Regulation of osteoprotegerin mRNA levels by prostaglandin E-2 in human bone marrow stroma cells. Biochem Biophys Res Commun. 247:1998;338-341.
3. Chauhan D., Uchiyama Y., Akbarali Y., Urashima M., Yamamoto K.-I., Libermann T.A., Anderson K.C. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-κB. Blood. 87:1996;1104-1112.
4. Colotta F., Re F., Muzio M., Bertini R., Polentuarutti N., Sironi M., Giri J.G., Dower S.K., Sims J.E., Mantovani A. Interelukin-1 type II receptor A decoy target for IL-1 that is regulated by IL-4 . Science. 261:1993;472-475.
5. Fujikawa Y., Quinn J.M.W., Sabokar A., McGee J. O'D., Athanasou N.A. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology. 137:1996;4058-4060.
6. Fuller K., Chambers T.J. Effects of arachidonic acid metabolites on bone resorption by isolated osteoclasts. J Bone Miner Res. 4:1989;209-215.
7. Haynes D.R., Boyle S., Rogers S.D., Howie D.W., Vernon-Roberts B. Variation in cytokines induced by particles from different prosthetic materials. Clin Orthop Rel Res. 352:1998;223-230.
8. Haynes D.R., Rogers S.D., Hay S., Pearcy M.J., Howie D.W. The differences in toxicity and release of bone-resorbing mediators induced by titanium and cobalt-chromium-alloy wear particles. J Bone Jt Surg. 75-A:1993;825-834.
9. Haynes D.R., Whitehouse M.W., Vernon-Roberts B. The prostaglandin E1 analogue, misoprostol, regulates cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3. Immunology. 76:1992;251-257.
10. Jarvis L.J., LeBien T.W. Stimulation of human bone marrow stromal cell tyrosine kinases and IL-6 production by contact with B lymphocytes. J Immunol. 155:1995;2359-2368.
11. Jimi E., Ikebe T., Takahashi N., Hirata M., Suda T., Koga T. Interleukin-1a activates an NF-κB-like factor in osteoclast-like cells. J Biol Chem. 271:1996;4605-4608.
12. Jimi E., Nakamura I., Ikebe T., Akiyama S., Takahashi N., Suda T. Activation of NF-κB is involved in the survival of osteoclasts promoted by interleukin 1. J Biol Chem. 273:1998;8799-8805.
13. Jimi E., Shuto T., Koga T. Macrophage colony stimulating factor and interleukin-1α maintain the survival of osteoclast-like cells. Endocrinology. 136:1995;808-811.
14. Kaspar R.L., Gehrke L. Peripheral blood mononuclear cells stimulated with C5a or lipopolysaccharide to synthesize equivalent levels of IL-1β mRNA show unequal IL-1β protein accumulation but similar polyribosome profiles. J Immunol. 153:1994;277-286.
15. Kelly R.W., Deam S., Cameron M.J., Seamark R.F. Measurement by radioimmunoassay of prostaglandins as their methyl oximes. Prostagland Leukot Med. 24:1987;1-14.
16. Kimble R.B., Srivastava S., Ross F.P., Matayoshi A., Pacifici R. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1-and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem. 271:1996;28890-28897.
17. 2, interleukin 1α, and tumor necrosis factor-α increase human osteoclast formation and bone resorption in vitro. Endocrinology. 139:1998;3157-3164.
18. Lorenzo J.A., Naprta A., Rao Y., Alander C., Glaccum M., Widmer M., Gronowicz G., Kalinowski J., Pilbeam C.C. Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy. Endocrinology. 139:1998;3022-3025.
19. Mallardo M., Giordano V., Dragonetti E., Scala G., Quinto I. DNA damaging agents increase the stability of interleukin-1α, interleukin-1β, and interleukin-6 transcripts and the production of the relative proteins. J Biol Chem. 269:1994;14899-14904.
20. Martin T.J., Ng K.W. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem. 56:1994;357-366.
21. McWatters A.T., An T., Matsushima K., Kleinerman E.S. Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes. J Pharmacol Exp Ther. 268:1994;1032-1039.
22. Ng K.W., Romas E., Donnan L., Findlay D.M. Bone biology. Reid I.R. Bailliere's Clinical Endocrinology and Metabolism - Metabolic Bone Disease. Vol. II. 1997;Bailliere-Tindall, London.
23. Okahashi N., Koide M., Jimi E., Suda T., Nishihara T. Caspases (interleukin-1β-converting enzyme family proteases) are involved in the regulation of the survival of osteoclasts. Bone. 23:1998;33-41.
24. Sarma U., Flanagan A.M. Macrophage colony stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow cultures. Blood. 88:1996;2531-2540.
25. 2 and bone resorption by recombinant human interleukin 1 alpha in fetal mouse bones. Biochem Biophys Res Commun. 138:1986;618-624.
26. 2 and bone resorption by recombinant human interleukin 1 alpha in fetal mouse bones. Biochem Biophys Res Commun. 138:1986;618-624.
27. Sato T., Morita I., Sakaguchi K., Nakahama K.-I., Smith W.L., Dewitt D.L., Murota S.-I. Involvement of prostaglandin H synthase-2 in osteoclast-like cell formation induced by interleukin-1β J Bone Miner Res. 11:1996;392-400.
28. Schindler R., Clark B.D., Dinarello C.A. Dissociation between interleukin-1β mRNA and protein synthesis in human peripheral blood mononuclear cells. J Biol Chem. 265:1990;10232-10237.
29. Sims J.E., Gayle M.A., Slack J.L., Alderson M.R., Bird T.A., Giri J.G., Dower S.K., Sims J.E., Mantovani A. Interleukin-1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci USA. 90:1993;6155-6159.
30. Uy H.L., Dallas M., Calland J.W., Boyce B.F., Mundy G.R., Roodman G.D. Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage. J Bone Miner Res. 10:1995;295-301.
31. Vargas S.J., Naprta A., Glaccum M., Lee S.K., Kalinowski J., Lorenzo J.A. Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor. J Bone Miner Res. 11:1996;1736-1744.
32. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S.-I., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 95:1998;3597-3602.
33. Yoshikubo T., Ozawa K., Takahashi K., Nishikawa M., Horiuchi N., Tojo A., Tani K., Kodama H., Asano S. Adhesion of NFS-60 myeloid leukemia cells to MC3T3-G2/PA6 stromal cells induces granulocyte colony stimulating factor production. Blood. 84:1994;415-420.